Drug Profile
Somatostatin eye drops - BCN Peptides
Alternative Names: COLIRIOBCN070660; Somatostatin 0.1% eye dropsLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator BCN Peptides
- Class Antihaemorrhagics; Antineoplastics; Cyclic peptides; Pancreatic hormones; Pituitary hormone release inhibiting hormones
- Mechanism of Action Corticotropin releasing hormone inhibitors; Growth hormone-releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetic retinopathy
Most Recent Events
- 29 Sep 2020 Discontinued - Phase-II/III for Diabetic retinopathy (In the elderly, In adults) in Denmark, France, Germany, Italy, Portugal, Spain, United Kingdom (Ophthalmic) before September 2020
- 29 Sep 2020 Discontinued - Phase-II/III for Diabetic retinopathy (In the elderly, Prevention, In adults) in Denmark, France, Germany, Italy, Portugal, Spain, United Kingdom (Ophthalmic) before September 2020
- 06 Oct 2017 Initial efficacy and adverse events data from the phase II/III EUROCONDOR trial in Diabetic retinopathy presented at the 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD-2017)